{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:26:08Z","timestamp":1788362768742,"version":"build-2803163510"},"posted":{"date-parts":[[2024,9,4]]},"group-title":"Neurology","reference-count":34,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The hippocampus is one of the first brain structures affected by Alzheimer\u2019s disease (AD), and its atrophy is a strong indicator of the disease. This study investigates the ability of plasma biomarkers of AD and AD-related dementias\u2014 amyloid-\u03b2 (A\u03b242\/40), phosphorylated tau-181 (p-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP)\u2014to predict hippocampal atrophy in adult individuals in Kinshasa, Democratic Republic of Congo (DRC).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Eighty-five adult individuals (40 healthy and 45 suspected AD) over 65 years old were evaluated using the Community Screening Instrument for Dementia and Alzheimer\u2019s Questionnaire (AQ). Core AD biomarkers (A\u03b242\/40 and p-tau181) and non-specific neurodegeneration biomarkers (NfL, GFAP) were measured in blood samples collected at the study visit. Hippocampal volumes were measured using magnetic resonance imaging (MRI). General linear regression was used to evaluate differences in biomarker concentrations by neurological status. Logistic regression models were used to create receiver operating characteristic curves and calculate areas under the curve (AUCs) with and without clinical covariates to determine the ability of biomarker concentrations to predict hippocampal atrophy. Plasma biomarkers were used either individually or in combination in the models.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Elevated p-tau181 was associated with left hippocampal (LH) atrophy p= 0.020). Only higher p-tau181 concentrations were significantly associated with 4.2-fold increased odds [OR=4.2 (1.5-18.4)] of hippocampal atrophy per standard deviation. The AUC of plasma biomarkers without clinical covariates to discriminate LH, RH, and total hippocampal (TH) or both hippocampi atrophy ranged between 90% to 94%, 76% to 82%, and 85% to 87%, respectively. The AUC of models including clinical covariates and AD biomarkers used in combination to discriminate LH, RH, and TH ranged between 94%-96%, 81%-84%, and 88%-90%, respectively.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These results indicate that, consistent with studies in other settings, core AD plasma biomarkers can predict hippocampal atrophy in a population in Sub-Saharan Africa.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.03.24313019","type":"posted-content","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T16:31:52Z","timestamp":1725467512000},"source":"Crossref","is-referenced-by-count":3,"title":["Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer\u2019s Disease in Kinshasa, Democratic Republic of Congo"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-733X","authenticated-orcid":false,"given":"Jean","family":"Ikanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kharine","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-6421","authenticated-orcid":false,"given":"Saranya Sundaram","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Schwinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Epenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Gikelekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Tshengele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculee","family":"Kavugho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mampunza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelo","family":"Mananga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argentina","family":"Lario Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jeromin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hanseeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-8323","authenticated-orcid":false,"given":"Alvaro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2024090602250617000_2024.09.03.24313019v1.1","first-page":"55","volume-title":"A Agrawal3 Biotech","volume":"12","year":"2022"},{"key":"2024090602250617000_2024.09.03.24313019v1.2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12816"},{"key":"2024090602250617000_2024.09.03.24313019v1.3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3233\/JAD-200056","article-title":"IL-1\u03b2, IL-6, IL-10, and TNF\u03b1 Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer\u2019s Disease Pathology","volume":"75","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2024090602250617000_2024.09.03.24313019v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11055-5"},{"key":"2024090602250617000_2024.09.03.24313019v1.5","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of Amyloid-\u03b2 and Tau Proteins in Alzheimer\u2019s Disease: Confuting the Amyloid Cascade","volume":"64","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2024090602250617000_2024.09.03.24313019v1.6","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091309"},{"key":"2024090602250617000_2024.09.03.24313019v1.7","first-page":"251","volume-title":"Translational psychiatry, 2021","volume":"11","year":"2021"},{"key":"2024090602250617000_2024.09.03.24313019v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70291-0"},{"key":"2024090602250617000_2024.09.03.24313019v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01249-0)"},{"key":"2024090602250617000_2024.09.03.24313019v1.10","doi-asserted-by":"crossref","unstructured":"Braak H , Cortex KDT-C, 2018 undefined. Spreading of tau pathology in sporadic Alzheimer\u2019s disease along cortico-cortical top-down connections. academic.oup.com H Braak , K Del Tredici Cerebral Cortex, 2018 academic.oup.com 2018; 28: 3372\u20133384.","DOI":"10.1093\/cercor\/bhy152"},{"key":"2024090602250617000_2024.09.03.24313019v1.11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac472"},{"key":"2024090602250617000_2024.09.03.24313019v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/nn834"},{"key":"2024090602250617000_2024.09.03.24313019v1.13","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2023.1287122\/FULL"},{"key":"2024090602250617000_2024.09.03.24313019v1.14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040783"},{"key":"2024090602250617000_2024.09.03.24313019v1.15","first-page":"813","article-title":"Cerebrospinal fluid A\u03b2 42\/40 corresponds better than A\u03b2 42 to amyloid PET in Alzheimer\u2019s disease","volume":"55","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease, 2017"},{"key":"2024090602250617000_2024.09.03.24313019v1.16","first-page":"1375","article-title":"Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease","volume":"78","year":"2021","journal-title":"jamanetwork.com"},{"key":"2024090602250617000_2024.09.03.24313019v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00214-3"},{"key":"2024090602250617000_2024.09.03.24313019v1.18","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2024.1320727\/FULL"},{"key":"2024090602250617000_2024.09.03.24313019v1.19","first-page":"e104","article-title":"The Cleo Roberts M. Development and Validation of the Alzheimer\u2019s Questionnaire (AQ)","volume":"1","year":"2015","journal-title":"J Nat Sci"},{"key":"2024090602250617000_2024.09.03.24313019v1.20","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F"},{"key":"2024090602250617000_2024.09.03.24313019v1.21","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2024090602250617000_2024.09.03.24313019v1.22","doi-asserted-by":"publisher","DOI":"10.1159\/000320247"},{"key":"2024090602250617000_2024.09.03.24313019v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/ALZ.13003"},{"key":"2024090602250617000_2024.09.03.24313019v1.24","doi-asserted-by":"publisher","DOI":"10.1002\/ALZ.12510"},{"key":"2024090602250617000_2024.09.03.24313019v1.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.6.1318"},{"key":"2024090602250617000_2024.09.03.24313019v1.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4726-3"},{"key":"2024090602250617000_2024.09.03.24313019v1.27","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018171888"},{"key":"2024090602250617000_2024.09.03.24313019v1.28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1159\/000449424","article-title":"Hippocampal Volumetry as a Biomarker for Dementia in People with Low Education","volume":"6","year":"2016","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"2024090602250617000_2024.09.03.24313019v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/ALZ.13859"},{"key":"2024090602250617000_2024.09.03.24313019v1.30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JAD-230206","article-title":"Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer\u2019s Disease in Democratic Republic of Congo","volume":"96","year":"2023","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2024090602250617000_2024.09.03.24313019v1.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03418-8"},{"key":"2024090602250617000_2024.09.03.24313019v1.32","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2022.816043\/FULL"},{"key":"2024090602250617000_2024.09.03.24313019v1.33","first-page":"1649","volume-title":"Alzheimer\u2019s & Dementia, 2021","volume":"17","author":"Wiley Online Library","year":"2021"},{"key":"2024090602250617000_2024.09.03.24313019v1.34","doi-asserted-by":"publisher","DOI":"10.1093\/BRAINCOMMS\/FCAB211"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.03.24313019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:11:03Z","timestamp":1768507863000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.09.03.24313019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1101\/2024.09.03.24313019","relation":{},"subject":[],"published":{"date-parts":[[2024,9,4]]},"subtype":"preprint"}}